These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25178985)

  • 21. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.
    Graff RE; Meisner A; Ahearn TU; Fiorentino M; Loda M; Giovannucci EL; Mucci LA; Pettersson A
    Br J Cancer; 2016 Apr; 114(8):939-44. PubMed ID: 26986253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer.
    Fodstad P; Bjøro T; Torlakovic G; Fossa SD
    J Urol; 2002 Sep; 168(3):1188-92. PubMed ID: 12187265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
    Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
    Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Allen NE; Key TJ; Dossus L; Rinaldi S; Cust A; Lukanova A; Peeters PH; Onland-Moret NC; Lahmann PH; Berrino F; Panico S; Larrañaga N; Pera G; Tormo MJ; Sánchez MJ; Ramón Quirós J; Ardanaz E; Tjønneland A; Olsen A; Chang-Claude J; Linseisen J; Schulz M; Boeing H; Lundin E; Palli D; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Bingham S; Khaw KT; Bueno-de-Mesquita HB; Trichopoulou A; Trichopoulos D; Naska A; Tumino R; Riboli E; Kaaks R
    Endocr Relat Cancer; 2008 Jun; 15(2):485-97. PubMed ID: 18509001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of serum sex-steroid hormones and prostate volume in African American men.
    Joseph MA; Wei JT; Harlow SD; Cooney KA; Dunn RL; Jaffe CA; Montie JE; Schottenfeld D
    Prostate; 2002 Dec; 53(4):322-9. PubMed ID: 12430143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
    Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
    Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer.
    Kumazawa T; Tsuchiya N; Wang L; Sato K; Kamoto T; Ogawa O; Nakamura A; Kato T; Habuchi T
    Int J Cancer; 2004 May; 110(1):140-4. PubMed ID: 15054879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A
    Toren P; Hoffman A; Ding K; Joncas FH; Turcotte V; Caron P; Pouliot F; Fradet Y; Lévesque É; Guillemette C; Klotz L
    Clin Cancer Res; 2018 Nov; 24(21):5305-5312. PubMed ID: 30021911
    [No Abstract]   [Full Text] [Related]  

  • 35. Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer.
    Hamilton-Reeves JM; Rebello SA; Thomas W; Slaton JW; Kurzer MS
    J Nutr; 2007 Jul; 137(7):1769-75. PubMed ID: 17585029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
    Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
    Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
    Hsing AW; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk.
    Mondul AM; Rohrmann S; Menke A; Feinleib M; Nelson WG; Platz EA; Albanes D
    Cancer Causes Control; 2011 Jun; 22(6):827-36. PubMed ID: 21424597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.